Infection With Unknown Origin in the Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

966 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients suspected with infection is one of the major groups, who are admitted to the Danish Emergency Departments (ED). Currently, there is no overall description of the distribution of these infections. The aim of this study is to characterize ED patients with a suspected infection whereby the focus of the infection is of an unknown origin.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Initial Patient Evaluation in the Emergency Department With Point-of-Care Ultrasonography

NCT02099045

Point of Care Ultrasonography in the Emergency Department.

UNKNOWN

Complaints and Presumptive Diagnosis in a Danish Emergency Department

NCT01747434

Symptoms on Admission Presumptive Diagnosis on Admission Final Diagnosis

COMPLETED

Sensitivity and Specificity of Urinary Dipstick in Emergency Departments

NCT04059211

Proteinuria

COMPLETED

Implementation of the Individual Danish Emergency Process Triage

NCT04571021

Acute Disease Emergencies Clinical Syndrome

COMPLETED NA

National Early Warning Score and D-dimer to Identify Medical Patients At Low Risk of 30-day Mortality

NCT03108807

Medical Patients in the Emergency Department

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bacteria resistant to antibiotics are associated with high antibiotic consumption and are identified by the World Health Organisation as a major public health threat. Despite efforts to optimize antibiotic consumption in Denmark, the total consumption in the hospital sector increased from 2009-2018 and the incidence of multi-resistance bacteria (MRB) is increasing. A Danish multicenter study has shown that every 20th patient in the emergency department has MRB. Patients with an infection of unknown origin tend to be prescribed a broad-spectrum antibiotic, as physicians endeavour to target probable origins in the body. The uncertainty associated with the diagnosis may lead to an overconsumption of antibiotics, which contributes to increased development of resistant bacteria and threatens future treatment options.

The aim of this study is to characterize patients admitted to the ED suspected with infection. The study will have three objectives:

* To describe the distribution of ED infections according to the registered diagnosis in the medical record compared to a clinical expert panel assessment
* To identify clinically relevant information available at admission associated with a patients infection of unknown origin.
* To investigate the association between an adverse event and clinically relevant information for patients with infection of unknown origin

The investigators' hypothesis is that with an improvement of knowledge about patients with an infection of unknown origin, a more accurate diagnosis can be made leading to a more appropriate antibiotic therapy and contributing to the fight against resistance to antibiotics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with a suspected infection

Acutely admitted patients from the emergency department across 3 sites who have a suspected infection.

Broader Medical history and clinical tests

Intervention Type DIAGNOSTIC_TEST

Patients will be treated with standard care plus additional blood tests, urine culture and urine flow cytometry,

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Broader Medical history and clinical tests

Patients will be treated with standard care plus additional blood tests, urine culture and urine flow cytometry,

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults admitted to the ED will be invited to participate in the study, if the physician, receiving the patient, suspect the patient has an infection (e.g. indication for blood culture).

Exclusion Criteria

* If the attending physician considers that participation will delay a life-saving treatment or patient needs direct transfer to the intensive care unit.
* Admission within the last 14 days
* Verified COVID-19 disease within 14 days before admission
* Pregnant women
* Severe immunodeficiencies: Primary immunodeficiencies and secondary immunodeficiencies (HIV positive CD4 \<200, Patients receiving immunosuppressive treatment (ATC L04A), Corticosteroid treatment (\>20 mg/day prednisone or equivalent for \>14 days within the last 30 days), Chemotherapy within 30 days)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No